title: Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Hodo
authors.forename: Kirokazu
authors.initials: K
authors.lastname: Tsuji
authors.forename: Eishiro
authors.initials: E
authors.lastname: Mizukoshi
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Yamashita
authors.forename: Akito
authors.initials: A
authors.lastname: Sakai
authors.forename: Yasunari
authors.initials: Y
authors.lastname: Nakamoto
authors.forename: Masao
authors.initials: M
authors.lastname: Honda
authors.forename: Shuichi
authors.initials: S
authors.lastname: Kaneko
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects; D006526:Hepatitis C / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D016031:Liver Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D012008:Recurrence; D012010:Red-Cell Aplasia, Pure / Q000097:blood / Q000139:chemically induced*; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D012254:Ribavirin; D009173:Mycophenolic Acid